{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:41:15Z","timestamp":1792514475806,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["PL-TW\/VI\/2\/2019"],"award-info":[{"award-number":["PL-TW\/VI\/2\/2019"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bj.2024.100729","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:36:27Z","timestamp":1713785787000},"page":"100729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-9208","authenticated-orcid":false,"given":"Katarzyna","family":"Bartold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Iskierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush Sindhu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-5170","authenticated-orcid":false,"given":"Wlodzimierz","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","article-title":"Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management","volume":"35","author":"Wijsenbeek","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"10354","key":"10.1016\/j.bj.2024.100729_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib3","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3390\/ijms24032405","article-title":"Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): genetics, cellular pathophysiology, and biologic Drivers","volume":"24","author":"Cerro Chiang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/23120541.00630-2021","article-title":"The prevalence and burden of interstitial lung diseases in the USA","volume":"8","author":"Jeganathan","year":"2022","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment","volume":"161","author":"Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib6","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.bj.2024.100729_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm7080201","article-title":"Idiopathic pulmonary fibrosis (IPF): an Overview","volume":"7","author":"Barratt","year":"2018","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.bj.2024.100729_bib8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.drudis.2020.09.019","article-title":"Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities","volume":"25","author":"Cruwys","year":"2020","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-2600(16)30325-3","article-title":"The diagnosis of idiopathic pulmonary fibrosis: current and future approaches","volume":"5","author":"Martinez","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/13993003.01504-2015","article-title":"Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada","volume":"48","author":"Hopkins","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thx.2010.148031","article-title":"The rising incidence of idiopathic pulmonary fibrosis in the UK","volume":"66","author":"Navaratnam","year":"2011","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.bj.2024.100729_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","article-title":"Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001\u201311","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12325-018-0693-1","article-title":"Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UK","volume":"35","author":"Strongman","year":"2018","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.bj.2024.100729_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40273-018-0631-8","article-title":"The burden of Illness of idiopathic pulmonary fibrosis: a comprehensive evidence review","volume":"36","author":"Diamantopoulos","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12890-015-0074-3","article-title":"Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis","volume":"15","author":"Kaunisto","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2213-2600(14)70011-6","article-title":"Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01603-2017","article-title":"Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001\u20132013","volume":"51","author":"Marshall","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000479976","article-title":"An open-label study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (RECAP)","volume":"94","author":"Costabel","year":"2017","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000512315","article-title":"S2K guideline for diagnosis of idiopathic pulmonary fibrosis","volume":"100","author":"Behr","year":"2021","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1378\/chest.14-0976","article-title":"CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis","volume":"147","author":"Chung","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib25","doi-asserted-by":"crossref","first-page":"W458","DOI":"10.2214\/AJR.12.9437","article-title":"UIP diagnosed at surgical lung biopsy, 2000-2009: HRCT patterns and proposed classification system","volume":"200","author":"Gruden","year":"2013","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0003-4975(00)01913-5","article-title":"A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease","volume":"70","author":"Miller","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1513\/AnnalsATS.201809-604CME","article-title":"2018 Clinical practice guideline summary for Clinicians: diagnosis of idiopathic pulmonary fibrosis","volume":"16","author":"Thomson","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ajpath.2014.02.003","article-title":"Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the National Heart, Lung, and Blood Institute","volume":"184","author":"Thannickal","year":"2014","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib30","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1172\/JCI74368","article-title":"Fibrosis: ultimate and proximate causes","volume":"124","author":"Thannickal","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.bj.2024.100729_bib32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201505-0862OC","article-title":"Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin Index Distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib33","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1039\/D2RA07005G","article-title":"Matrix metalloproteinase profiling and their roles in disease","volume":"13","author":"Chang","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bj.2024.100729_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.122054","article-title":"Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9","volume":"225","author":"Ar\u00e9valo","year":"2021","journal-title":"Talanta"},{"issue":"35","key":"10.1016\/j.bj.2024.100729_bib35","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1039\/C6CC00928J","article-title":"An electrochemical peptide cleavage-based biosensor for matrix metalloproteinase-2 detection with exonuclease III-assisted cycling signal amplification","volume":"52","author":"Wang","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.bj.2024.100729_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep14197","article-title":"Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes","volume":"5","author":"Chi","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5483\/BMBRep.2015.48.6.054","article-title":"Fluorescent and Bioluminescent Nanoprobes for in vitro and in vivo detection of matrix metalloproteinase activity","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1364\/BOE.6.002076","article-title":"Sensitive surface-enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers","volume":"6","author":"Gong","year":"2015","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.bj.2024.100729_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.129369","article-title":"Simple and robust: the claims of protein sensing by molecularly imprinted polymers","volume":"330","author":"Yarman","year":"2021","journal-title":"Sens Actuators B Chem"},{"key":"10.1016\/j.bj.2024.100729_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114203","article-title":"Molecularly imprinted polymer-based extended-gate field-effect transistor (EG-FET) chemosensor for selective determination of matrix metalloproteinase-1 (MMP-1) protein","volume":"208","author":"Bartold","year":"2022","journal-title":"Biosens Bioelectron"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/bios12111018","article-title":"Peptide selection of MMP-1 for electrochemical sensing with epitope-imprinted poly(TPARA-co-EDOT)s","volume":"12","author":"Lee","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.bj.2024.100729_bib42","article-title":"Peptide-imprinted conductive polymer on continuous monolayer molybdenum disulfide transferred electrodes for electrochemical sensing of Matrix Metalloproteinase-1 in lung cancer culture medium","volume":"13","author":"Lee","year":"2023","journal-title":"Biosens Bioelectron X"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.bj.2024.100729_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trac.2018.10.027","article-title":"Biosensors for measuring matrix metalloproteinases: an emerging research field","volume":"110","author":"Kirchhain","year":"2019","journal-title":"TrAC - Trends Anal Chem"},{"issue":"12","key":"10.1016\/j.bj.2024.100729_bib45","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.3390\/ijms22126255","article-title":"Molecular biomarkers in idiopathic pulmonary fibrosis: state of the Art and future Directions","volume":"22","author":"Stainer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"153","key":"10.1016\/j.bj.2024.100729_bib46","doi-asserted-by":"crossref","first-page":"190021","DOI":"10.1183\/16000617.0021-2019","article-title":"The therapy of idiopathic pulmonary fibrosis: what is next?","volume":"28","author":"Somogyi","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.bj.2024.100729_bib47","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1164\/ajrccm.163.7.2009041","article-title":"Exhaled markers of pulmonary disease","volume":"163","author":"Kharitonov","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12931-019-0971-8","article-title":"Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review","volume":"20","author":"Hayton","year":"2019","journal-title":"Respir Res"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib50","article-title":"Exhaled nitric oxide levels to guide treatment for adults with asthma","volume":"9","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.freeradbiomed.2006.11.031","article-title":"Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis","volume":"42","author":"Hsu","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib52","first-page":"39","article-title":"Exhaled nitric oxide is not increased in pulmonary sarcoidosis","volume":"33","author":"Cameli","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"17","key":"10.1016\/j.bj.2024.100729_bib53","first-page":"3015","article-title":"Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema","volume":"125","author":"Zhao","year":"2012","journal-title":"Chin Med J"},{"issue":"13","key":"10.1016\/j.bj.2024.100729_bib54","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.3390\/molecules27134279","article-title":"An evidence-based review of application devices for nitric oxide concentration determination from exhaled air in the diagnosis of inflammation and treatment monitoring","volume":"27","author":"Wyszy\u0144ska","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1465-9921-12-81","article-title":"Increase of nitrosative stress in patients with eosinophilic pneumonia","volume":"12","author":"Furukawa","year":"2011","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12890-017-0456-9","article-title":"Reference values of fractional excretion of exhaled nitric oxide among non-smokers and current smokers","volume":"17","author":"Tor\u00e9n","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib57","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aa7957","article-title":"Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects","volume":"11","author":"H\u00f6gman","year":"2017","journal-title":"J Breath Res"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jcm5090080","article-title":"Plasma vascular Endothelial growth factor concentration and alveolar nitric oxide as potential predictors of disease progression and mortality in idiopathic pulmonary fibrosis","volume":"5","author":"Kotecha","year":"2016","journal-title":"J Clin Med"},{"issue":"17","key":"10.1016\/j.bj.2024.100729_bib59","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.3390\/ijms21176187","article-title":"Extended exhaled nitric oxide analysis in interstitial lung diseases: a systematic review","volume":"21","author":"Cameli","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib60","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.rmed.2013.07.007","article-title":"Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?","volume":"107","author":"Guilleminault","year":"2013","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.05.00029705","article-title":"Exhaled breath condensate: methodological recommendations and unresolved questions","volume":"26","author":"Horv\u00e1th","year":"2005","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rmed.2009.10.018","article-title":"A profile of volatile organic compounds in breath discriminates COPD patients from controls","volume":"104","author":"Van Berkel","year":"2010","journal-title":"Respir Med"},{"issue":"55","key":"10.1016\/j.bj.2024.100729_bib63","doi-asserted-by":"crossref","first-page":"35627","DOI":"10.1039\/D2RA05764F","article-title":"Detection of respiratory inflammation biomarkers in non-processed exhaled breath condensate samples using reduced graphene oxide","volume":"12","author":"Gholizadeh","year":"2022","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/micronano.2017.22","article-title":"Toward point-of-care management of chronic respiratory conditions: electrochemical sensing of nitrite content in exhaled breath condensate using reduced graphene oxide","volume":"3","author":"Gholizadeh","year":"2017","journal-title":"Microsys Nanoeng"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib65","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1021\/acs.analchem.2c04604","article-title":"Analysis of a Broad range of Carbonyl metabolites in exhaled breath by UHPLC-MS","volume":"95","author":"Xie","year":"2023","journal-title":"Anal Chem"},{"issue":"12","key":"10.1016\/j.bj.2024.100729_bib66","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1365-2222.2008.03108.x","article-title":"Comparison of cysteinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid","volume":"38","author":"Ono","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2362.2006.01636.x","article-title":"Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis","volume":"36","author":"Psathakis","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib68","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.rmed.2009.04.014","article-title":"Oxidative stress in the pathogenesis of diffuse lung diseases: a review","volume":"103","author":"Bargagli","year":"2009","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/039463201402700106","article-title":"ROCK activation in lung of idiopathic pulmonary fibrosis with oxidative stress","volume":"27","author":"Shimizu","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib70","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/6\/1\/016004","article-title":"Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis","volume":"6","author":"Chow","year":"2012","journal-title":"J Breath Res"},{"issue":"8","key":"10.1016\/j.bj.2024.100729_bib71","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/jcm9082523","article-title":"Exhaled biomarkers in idiopathic pulmonary fibrosis\u2014a six-month follow-up study in patients treated with pirfenidone","volume":"9","author":"Jaskiewicz","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib72","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1378\/chest.128.4.2387","article-title":"Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases","volume":"128","author":"Kanoh","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib73","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/3\/4\/046003","article-title":"Metallic elements in exhaled breath condensate of patients with interstitial lung diseases","volume":"3","author":"Corradi","year":"2009","journal-title":"J Breath Res"},{"issue":"9202","key":"10.1016\/j.bj.2024.100729_bib74","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(00)82017-6","article-title":"Risk of cryptogenic fibrosing alveolitis in metal workers","volume":"355","author":"Hubbard","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bj.2024.100729_bib75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/thx.2006.072892","article-title":"Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array","volume":"62","author":"Mazzone","year":"2007","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00408-017-9979-3","article-title":"Volatile organic compounds in exhaled breath of idiopathic pulmonary fibrosis for discrimination from healthy subjects","volume":"195","author":"Yamada","year":"2017","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib77","doi-asserted-by":"crossref","first-page":"1701817","DOI":"10.1183\/13993003.01817-2017","article-title":"Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label","volume":"51","author":"de Vries","year":"2018","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.bj.2024.100729_bib78","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdz279","article-title":"Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath","volume":"30","author":"de Vries","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.bj.2024.100729_bib79","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.rmed.2013.03.011","article-title":"An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls","volume":"107","author":"Dragonieri","year":"2013","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.bj.2024.100729_bib80","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/jcm8101698","article-title":"Exploring the ability of electronic nose technology to recognize interstitial lung diseases (ILD) by non-invasive breath Screening of exhaled volatile compounds (VOC): a Pilot study from the European IPF registry (eurIPFreg) and Biobank","volume":"8","author":"Krauss","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000083398","article-title":"Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis","volume":"72","author":"Antoniou","year":"2005","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.bj.2024.100729_bib82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.mcp.0000239547.62949.82","article-title":"Induced sputum in interstitial lung diseases","volume":"12","author":"Fireman","year":"2006","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171344","article-title":"Sputum biomarkers in IPF: evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7","volume":"12","author":"Guiot","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41420-021-00437-9","article-title":"Role of interleukins in the pathogenesis of pulmonary fibrosis","volume":"7","author":"She","year":"2021","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12890-016-0249-6","article-title":"Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis","volume":"16","author":"Guiot","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thoraxjnl-2018-211897","article-title":"Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis","volume":"74","author":"Njock","year":"2019","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib87","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1183\/09031936.02.00262402","article-title":"Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Beeh","year":"2002","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib88","doi-asserted-by":"crossref","first-page":"L709","DOI":"10.1152\/ajplung.00418.2012","article-title":"Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis","volume":"304","author":"McKleroy","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/thoraxjnl-2013-204596","article-title":"Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis","volume":"70","author":"DePianto","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","article-title":"Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis","volume":"185","author":"Richards","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/apt.12820","article-title":"Review article: the efficacy of biomarkers in chronic fibroproliferative diseases \u2013 early diagnosis and prognosis, with liver fibrosis as an exemplar","volume":"40","author":"Karsdal","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib92","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib93","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/resp.14056","article-title":"High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis","volume":"26","author":"Hoyer","year":"2021","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12931-021-01801-0","article-title":"Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis","volume":"22","author":"Jessen","year":"2021","journal-title":"Respiratory research"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib95","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12890-021-01684-3","article-title":"Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis","volume":"21","author":"Jessen","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respir Res"},{"issue":"Pt 24","key":"10.1016\/j.bj.2024.100729_bib97","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bj.2024.100729_bib98","first-page":"38","article-title":"A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis","volume":"17","author":"Leeming","year":"2019","journal-title":"Biochem Biophys Rep"},{"issue":"11","key":"10.1016\/j.bj.2024.100729_bib99","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s00259-022-05814-9","article-title":"[(68) Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity","volume":"49","author":"Rosenkrans","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a Translational Exploratory study","volume":"63","author":"R\u00f6hrich","year":"2022","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib101","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acsnano.0c08349","article-title":"Quo Vadis, Nanoparticle-Enabled in vivo fluorescence imaging?","volume":"15","author":"Ximendes","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.bj.2024.100729_bib102","article-title":"Aggregation-induced Nonlinear Optical effects of AIEgen Nanocrystals for Ultradeep in vivo Bioimaging","volume":"31(44)","author":"Zheng","year":"2019","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib103","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1038\/s41598-018-25383-y","article-title":"Near-infrared fluorescence imaging directly visualizes lymphatic Drainage Pathways and connections between Superficial and Deep lymphatic systems in the mouse Hindlimb","volume":"8","author":"Nakajima","year":"2018","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.bj.2024.100729_bib104","doi-asserted-by":"crossref","first-page":"35365","DOI":"10.1021\/acsami.1c08076","article-title":"Carbon dots with Absorption red-Shifting for two-photon fluorescence imaging of tumor tissue pH and Synergistic Phototherapy","volume":"13","author":"Bai","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bj.2024.100729_bib105","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1038\/ncomms5206","article-title":"Ultrafast fluorescence imaging in vivo with conjugated polymer fluorophores in the second near-infrared window","volume":"5","author":"Hong","year":"2014","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.bj.2024.100729_bib106","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1039\/D0CS01183E","article-title":"Small-molecule fluorescence-based probes for interrogating major organ diseases","volume":"50","author":"Han","year":"2021","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.bj.2024.100729_bib107","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1039\/C9QM00667B","article-title":"Recent advances and prospects of carbon dots in cancer nanotheranostics","volume":"4","author":"Jia","year":"2020","journal-title":"Mater Chem Front"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib108","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13287-018-1083-y","article-title":"Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats","volume":"9","author":"Li","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.bj.2024.100729_bib109","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1021\/acsnano.9b04430","article-title":"Tuning Organelle Specificity and photodynamic therapy Efficiency by molecular function Design","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.bj.2024.100729_bib110","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1002\/anie.202005899","article-title":"NIR-II AIEgens: a Win-Win integration towards Bioapplications","volume":"60","author":"Xu","year":"2021","journal-title":"Angew Chem, Int Ed"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib111","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1039\/D0TB02440F","article-title":"Mitochondria and lysosome-targetable fluorescent probes for hydrogen peroxide","volume":"9","author":"Wei","year":"2021","journal-title":"J Mater Chem B"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib112","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acssensors.0c02519","article-title":"Real-time evaluation of hydrogen peroxide Injuries in pulmonary fibrosis mice models with a mitochondria-targeted near-infrared fluorescent probe","volume":"6","author":"Song","year":"2021","journal-title":"ACS Sens"},{"issue":"17","key":"10.1016\/j.bj.2024.100729_bib113","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1021\/acs.analchem.9b02971","article-title":"Visualization of lung inflammation to pulmonary fibrosis via Peroxynitrite fluctuation","volume":"91","author":"Zhan","year":"2019","journal-title":"Anal Chem"},{"issue":"8","key":"10.1016\/j.bj.2024.100729_bib114","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1021\/acs.analchem.9b00713","article-title":"Evaluation of glutathione S-transferase inhibition effects on idiopathic pulmonary fibrosis therapy with a near-infrared fluorescent probe in cell and mice models","volume":"91","author":"He","year":"2019","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pupt.2006.10.005","article-title":"Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis","volume":"21","author":"Daniil","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.bj.2024.100729_bib116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0378-4274(99)00230-1","article-title":"Glutathione S-transferase: genetics and role in toxicology","volume":"112\u2013113","author":"Strange","year":"2000","journal-title":"Toxicol Lett"},{"issue":"24","key":"10.1016\/j.bj.2024.100729_bib117","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1021\/bi00075a026","article-title":"Extracellular glutathione is a source of cysteine for cells that express .gamma.-glutamyl transpeptidase","volume":"32","author":"Hanigan","year":"1993","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib118","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2005.10.005","article-title":"Expression of \u03b3-glutamyltransferase in cancer cells and its significance in drug resistance","volume":"71","author":"Pompella","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bj.2024.100729_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.128565","article-title":"A near-infrared fluorescent probe for evaluating glutamyl transpeptidase fluctuation in idiopathic pulmonary fibrosis cell and mice models","volume":"322","author":"He","year":"2020","journal-title":"Sens Actuators B Chem"},{"issue":"9","key":"10.1016\/j.bj.2024.100729_bib120","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1021\/acs.analchem.1c05643","article-title":"Evaluation of nitric oxide fluctuation via a fast, responsive fluorescent probe in idiopathic pulmonary fibrosis cells and mice models","volume":"94","author":"Xu","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.bj.2024.100729_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108669","article-title":"Citrus alkaline extracts prevent fibroblast senescence to ameliorate pulmonary fibrosis via activation of COX-2","volume":"112","author":"Feng","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.bj.2024.100729_bib122","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2011-0005OC","article-title":"The role of cyclooxygenase-2 in Mechanical Ventilation\u2013induced lung injury","volume":"47","author":"Robertson","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bj.2024.100729_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101877","article-title":"The role of increased red cell distribution width as a negative prognostic marker in patients with COPD","volume":"60","author":"Karampitsakos","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bj.2024.100729_bib124","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12931-021-01725-9","article-title":"Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis","volume":"22","author":"Karampitsakos","year":"2021","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","article-title":"Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study","volume":"7","author":"Scott","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100729_bib126","doi-asserted-by":"crossref","first-page":"1901855","DOI":"10.1183\/13993003.01855-2019","article-title":"Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry","volume":"55","author":"Teoh","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.bj.2024.100729_bib127","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1378\/chest.12-1368","article-title":"The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis","volume":"143","author":"Nathan","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.bj.2024.100729_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2018.01.011","article-title":"Increased red cell distribution width: a novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease","volume":"136","author":"Epstein","year":"2018","journal-title":"Respir Med"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:51:32Z","timestamp":1778867492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417024000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2319417024000325"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100729","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100729"}}